Can artificial intelligence contribute to cancer research? It can. In fact, “we are already seeing its potential”. Its application “is going to help us a lot to personalise medicine for cancer patients,” says René Rodríguez, principal investigator of the Sarcomas and Experimental Therapies group at Ispa-Finba. His team participates in the Organaides programme, which also involves the Head and Neck Tumour Oncology research group, led by Mónica Álvarez, the Idonial Foundation and Izertis.